Hanselaar A G, Vooijs G P, Van't Hof-Grootenboer A E, Pahlplatz M M
Department of Pathology, University Hospital Nijmegen, The Netherlands.
Cytometry. 1990;11(8):901-6. doi: 10.1002/cyto.990110808.
Cytophotometric analysis was performed in nuclei retrieved from paraffin-embedded cervical tissue from 57 cases of CIN III. CIN III lesions of patients without invasive squamous cell carcinoma (N = 37) were regarded to represent a mixture of progressive and nonprogressive lesions. The CIN III lesions of patients with a synchronous invasive squamous cell carcinoma (N = 20) were regarded as representing truly progressive precursor lesions (CIN.INV). Twenty-one photometric features describing geometrical, density, and texture characteristics were extracted from the digitized nuclear images. Statistical analysis of cytophotometric data indicated significant differences between the group of CIN III lesions and CIN.INV lesions. A cluster analysis, using one co-occurrency texture feature (S-HOMOG), one density feature (S-DI), and two geometrical features (S-AREA and M-CIRC), showed that two clusters (C1 and C2) were present in the total group of CIN III and CIN.INV lesions. The vast majority of CIN.INV lesions was member of one and the same cluster C1. The CIN III group appeared to consist of a mixture of two clusters, 54% C1 and 46% C2 lesions. Of patients 45 years or younger, the majority (62%) of CIN III lesions had feature values, corresponding with those of cluster C1, and as such possibly with a potentially progressive course. In patients older than 45 years the percentage of CIN III lesions with C1 feature values was 27%.
对从57例CIN III石蜡包埋宫颈组织中获取的细胞核进行了细胞光度分析。无浸润性鳞状细胞癌患者(N = 37)的CIN III病变被视为代表进展性和非进展性病变的混合。伴有同步浸润性鳞状细胞癌患者(N = 20)的CIN III病变被视为代表真正进展性的前驱病变(CIN.INV)。从数字化核图像中提取了21个描述几何、密度和纹理特征的光度特征。细胞光度数据的统计分析表明CIN III病变组和CIN.INV病变组之间存在显著差异。使用一个共现纹理特征(S-HOMOG)、一个密度特征(S-DI)和两个几何特征(S-AREA和M-CIRC)进行聚类分析,结果显示在CIN III和CIN.INV病变的总组中存在两个聚类(C1和C2)。绝大多数CIN.INV病变属于同一个聚类C1。CIN III组似乎由两个聚类的混合组成,54%为C1病变,46%为C2病变。在45岁及以下的患者中,大多数(62%)CIN III病变具有与聚类C1相对应的特征值,因此可能具有潜在的进展过程。在45岁以上的患者中,具有C1特征值的CIN III病变百分比为27%。